Pollen Distress Spray
NDC Package 50845-0284-2
Package Information
Pollen Distress (allium cepa, apis mellifica, aralia racemosa, arundo mauritanica, baptisia tinctoria, echinacea (angustifolia), euphrasia officinalis, gelsemium sempervirens, histaminum hydrochloricum, lycopodium clavatum, rhus tox, sabadilla, sanguinaria canadensis, urtica urens) sprays is adults and children over 12: Spray twice under the tongue three times per day. This formulation utilizes a spray delivery system. Marketed by Liddell Laboratories, Inc., this product is identified by NDC 50845-0284.
Identification & Billing
Clinical Specifications
- APIS MELLIFERA 6 [hp_X]/mL
- ARALIA RACEMOSA ROOT 6 [hp_X]/mL
- ARUNDO PLINIANA ROOT 30 [hp_C]/mL
- BAPTISIA TINCTORIA ROOT 3 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE 4 [hp_X]/mL
- EUPHRASIA STRICTA 6 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT 200 [hp_C]/mL
- HISTAMINE DIHYDROCHLORIDE 12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/mL
- ONION 6 [hp_X]/mL
- SANGUINARIA CANADENSIS ROOT 200 [hp_C]/mL
- SCHOENOCAULON OFFICINALE SEED 6 [hp_C]/mL
- TOXICODENDRON PUBESCENS LEAF 200 [hp_X]/mL
- URTICA URENS WHOLE 3 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Bee Venoms - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Standardized Insect Venom Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 50845 - Liddell Laboratories, Inc.
- 50845-0284 - Pollen Distress
- 50845-0284-2 - 1 BOTTLE, SPRAY in 1 CARTON / 30 mL in 1 BOTTLE, SPRAY (50845-0284-1)
- 50845-0284 - Pollen Distress
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50845-0284-2 identifies a specific commercial package of 1 bottle, spray in 1 carton / 30 ml in 1 bottle, spray (50845-0284-1) of Pollen Distress, a human over the counter drug labeled by Liddell Laboratories, Inc.. This spray is formulated for oral use and contains apis mellifera; aralia racemosa root; arundo pliniana root; baptisia tinctoria root; echinacea angustifolia whole; euphrasia stricta; gelsemium sempervirens root; histamine dihydrochloride; lycopodium clavatum spore; onion; sanguinaria canadensis root; schoenocaulon officinale seed; toxicodendron pubescens leaf; urtica urens whole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Liddell Laboratories, Inc. on January 26, 2026. The current certification is valid through December 31, 2027.
How is this Liddell Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50845028402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.